US Broker Ratings

Twist Bioscience Corporation (TWST) Stock Analysis: A Healthcare Innovator with 42.76% Potential Upside

Twist Bioscience Corporation (NASDAQ: TWST) stands out in the healthcare sector, particularly within diagnostics and research. With its innovative approach to synthetic DNA-based products, the company..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 48% Upside Potential with Strong Buy Ratings

Vericel Corporation (NASDAQ: VCEL), a prominent player in the biotechnology sector, has captured the attention of investors with its innovative approach to cellular therapies and specialty..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Exploring a Potential 10% Upside in the Healthcare Sector

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN) emerges as a compelling opportunity for investors seeking exposure in the healthcare sector, particularly in the niche of pharmacy services..

Zai Lab Limited (ZLAB)

⚠️ No article content returned.

..

Perrigo Company plc (PRGO) Stock Analysis: Navigating a 48.72% Potential Upside with Robust Dividends

Perrigo Company plc (NYSE: PRGO), a staple in the healthcare sector, is making waves in the investor community with a noteworthy 48.72% potential upside, according to..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Unveiling a 90% Upside Potential

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) has garnered significant attention within the biotechnology sector, primarily due to its promising drug pipeline and strategic alliances with industry giants..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: A Compelling 38.40% Potential Upside with Strong Buy Ratings

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a pioneering biopharmaceutical company, has captured the attention of investors with its innovative approach to drug development and a notable potential..

Protagonist Therapeutics, Inc. (PTGX) Stock Report: Unveiling a 24% Potential Upside in the Biotech Sector

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) stands out in the competitive biotechnology sector, capturing the attention of investors with its promising pipeline and a significant potential upside...

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: A 133% Potential Upside in the Biotech Sector

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a clinical-stage biotechnology company based in San Diego, California, is making waves in the healthcare sector. With a market capitalization of..

PROCEPT BioRobotics (PRCT) Stock Analysis: A Promising 62.67% Upside in the Healthcare Sector

For investors eyeing the healthcare sector, PROCEPT BioRobotics Corporation (NASDAQ: PRCT) represents a compelling opportunity with significant growth potential. The company’s focus on innovative medical devices..

CONMED Corporation (CNMD) Stock Analysis: Evaluating a 14.25% Upside Potential in the Medical Device Sector

Investors with a keen interest in the healthcare sector, particularly in the medical devices industry, may find CONMED Corporation (NASDAQ: CNMD) a noteworthy consideration. With a..

Ardent Health, Inc. (ARDT) Stock Analysis: 52.72% Potential Upside Ignites Investor Interest

Ardent Health, Inc. (ARDT) presents a compelling opportunity for investors seeking exposure in the healthcare sector, particularly within the medical care facilities industry. Based in Brentwood,..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A 23.61% Upside Opportunity for Investors

Alignment Healthcare, Inc. (NASDAQ: ALHC) stands out in the healthcare sector with its impressive potential upside of 23.61%, making it a compelling consideration for investors eyeing..

Merus N.V. (MRUS) Stock Analysis: Exploring a 36.97% Potential Upside in Biotech

Merus N.V. (MRUS), a Netherlands-based biotechnology company, is making waves in the healthcare sector with its innovative approach to immuno-oncology. With a market capitalization of $4.99..

LifeStance Health Group, Inc. (LFST) Investor Outlook: Navigating a Potential 55.8% Upside

LifeStance Health Group, Inc. (NASDAQ: LFST) stands as a noteworthy player in the healthcare sector, specifically within the medical care facilities industry. Specializing in outpatient mental..

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: Unpacking a Potential 119.92% Upside

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) presents an intriguing opportunity in the biotechnology sector, standing at the crossroads of innovative drug development and promising market potential. With..

Enovis Corporation (ENOV) Stock Analysis: Exploring a 76.65% Upside Potential in the Medical Devices Sector

Enovis Corporation (NYSE: ENOV), a specialist in medical technology, presents a compelling opportunity for investors with a potential upside of 76.65%, based on the average target..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Evaluating a 29.59% Upside Potential

Amneal Pharmaceuticals, Inc. (AMRX), a leading player in the healthcare sector, is capturing attention with its robust market presence in the specialty and generic drug manufacturing..

Privia Health Group, Inc. (PRVA): Investor Outlook Highlights 40% Upside Potential

Privia Health Group, Inc. (NASDAQ: PRVA) is making waves in the healthcare sector with its innovative approach to physician enablement. Headquartered in Arlington, Virginia, this company..

Concentra Group Holdings Parent (CON): Investor Outlook and 22% Upside Potential

Concentra Group Holdings Parent, Inc. (CON), a key player in the U.S. healthcare sector, particularly within the medical care facilities industry, stands out with a market..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds